Skip to main content

Table 4 Variables measured by the continuous glucose monitoring system

From: Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study

 

Total

N = 47

DM

N = 22

Non-DM

N = 25

p value

DM vs. non-DM

MAGE, mg/dL

64.4 ± 19.1

78.5 ± 14.4

52.0 ± 13.2

<0.01

Mean blood glucose, mg/dL

130.2 ± 27.2

151.8 ± 23.5

111.1 ± 11.2

<0.01

Max blood glucose, mg/dL

222.9 ± 56.9

262.7 ± 43.2

187.8 ± 42.8

<0.01

Min blood glucose, mg/dL

80.2 ± 23.7

93.8 ± 23.2

68.2 ± 16.9

<0.01

Time in hyperglycemia, %

33.5 ± 31.1

59.5 ± 26.0

10.7 ± 10.0

<0.01

Time in hypoglycemia, %

3.5 ± 12.8

0.30 ± 0.9

6.3 ± 17.2

0.09

  1. Data are represented as mean ± standard deviation. Time in hyperglycemia: length of time during which blood glucose levels >140 mg/dL. Time in hypoglycemia: length of time during which blood glucose levels <70 mg/dL
  2. DM diabetes mellitus, MAGE mean amplitude of glycemic excursion
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840